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New Findings
 What is the central question of this study?
Can we experimentally replicate atrial pro-arrhythmic phenotypes associated with
important chronic clinical conditions, including physical inactivity, obesity, diabetes
mellitus and metabolic syndrome, compromising mitochondrial function, and clarify their
electrophysiological basis?
 What is the main finding and its importance?
Electrocardiographic and intracellular cardiomyocyte recording at progressively incremented
pacing rates demonstrated age-dependent atrial arrhythmic phenotypes in Langendorff-
perfused murine Pgc1β−/− hearts for the first time. We attributed these to compromised
actionpotential conductionandexcitationwavefronts,whilst excludingalterations in recovery
properties or temporal electrophysiological instabilities, clarifying these pro-arrhythmic
changes in chronic metabolic disease.
Atrial arrhythmias, most commonly manifesting as atrial fibrillation, represent a major clinical
problem. The incidence of atrial fibrillation increases with both age and conditions associated
with energetic dysfunction.Atrial arrhythmicphenotypeswere compared inyoung (12–16week)
and aged (>52 week) wild-type (WT) and peroxisome proliferative activated receptor, gamma,
coactivator 1 beta (Ppargc1b)-deficient (Pgc1β−/−) Langendorff-perfused hearts, previously
used to model mitochondrial energetic disorder. Electrophysiological explorations were
performed using simultaneous whole-heart ECG and intracellular atrial action potential (AP)
recordings. Two stimulation protocols were used: an S1S2 protocol, which imposed extrasystolic
stimuli at successively decremented intervals following regular pulse trains; and a regular pacing
protocol at successively incremented frequencies. Aged Pgc1β−/− hearts showed greater atrial
arrhythmogenicity, presenting as atrial tachycardia and ectopic activity. Maximal rates of AP
depolarization (dV/dtmax) were reduced in Pgc1β−/− hearts. Action potential latencies were
increased by the Pgc1β−/− genotype, with an added interactive effect of age. In contrast,
AP durations to 90% recovery (APD90) were shorter in Pgc1β−/− hearts despite similar
atrial effective recovery periods amongst the different groups. These findings accompanied
paradoxical decreases in the incidence anddurationof alternans in the aged andPgc1β−/− hearts.
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Limiting slopes of restitution curves of APD90 against diastolic interval were correspondingly
reduced interactively by Pgc1β−/− genotype and age. In contrast, reduced AP wavelengths were
associated with Pgc1β−/− genotype, both independently and interacting with age, through the
basic cycle lengths explored, with the aged Pgc1β−/− hearts showing the shortest wavelengths.
These findings thus implicate AP wavelength in possible mechanisms for the atrial arrhythmic
changes reported here.
(Received 19 July 2017; accepted after revision 26 September 2017; first published online 27 September 2017)
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Introduction
Arrhythmogenesis is a complex physiological pheno-
menon of dysregulated cardiac electrical activity, with
both short- and long-term consequences. The complex
embryological origins and anatomical structure of the
atria make them particularly vulnerable to arrhythmic
syndromes. Atrial fibrillation (AF) is of particular
clinical importance, affecting 1–3% of individuals in
Western countries (Friberg & Bergfeldt, 2013). The
processes underpinning its induction and maintenance
remain incompletely explained, but involve complex
interactions between altered cardiac electrical properties
and functional changes in the atria, which occur over
the short and long term. It has been suggested that
AF is a self-perpetuating process, triggered initially by
focal ectopic activity arising in the pulmonary veins that
drive cumulative electrical and structural remodelling
processes, themselves generating arrhythmic substrate
(Haı¨ssaguerre et al. 1998).
These changes are exacerbated by several interacting
upstream factors, with ageing and metabolic disease
central to a number of these. There is a pronounced
increase in the prevalence of AF with age, from 4% of
individuals aged 60–70 years to nearly 20% of individuals
80 years (Zoni-Berisso et al. 2014). Likewise, metabolic
factors may explain 60% of current upward trends
in incidences of AF (Miyasaka et al. 2006). Metabolic
disease and obesity have been implicated as risk factors,
themselves age dependent, for ventricular arrhythmias
(Adabag et al. 2015). Likewise, the risk of AF increases
with physical inactivity (Mozaffarian et al. 2008), obesity
(Tedrow et al. 2010), diabetes mellitus (Nichols et al.
2009) and metabolic syndrome (Watanabe et al. 2008).
Amelioration of metabolic disease improves both risk
profiles and responses to therapy (Tedrow et al. 2010).
Furthermore, it has been shown that manipulation of
key components of cellular energy production pathways
suppresses arrhythmia in known arrhythmogenic models
(Liu et al. 2009).
Mitochondrial functionmaybe integral to relationships
between ageing, metabolism and arrhythmia. Mitocho-
ndria provide >95% of the ATP required for Ca2+
homeostasis and maintenance of transmembrane ionic
gradients in addition to cardiacmuscle contraction (Barth
& Tomaselli, 2009). Abnormal mitochondrial structure
and function have been reported in animal models of
AF (Ausma et al. 1997). Analysis of mitochondria from
cardiomyocytes of human AF patients demonstrates
increased DNA damage (Tsuboi et al. 2001; Lin et al.
2003), structural abnormalities (Bukowska et al. 2008)
and impaired function (Lin et al. 2003). Furthermore,
a number of targeted mitochondrial DNA mutations
accumulate with age and show increased incidences
in AF (Lai et al. 2003). Mitochondrial dysfunction
also results in generation of reactive oxygen species,
which has been implicated in the pathogenesis of
human AF (Korantzopoulos et al. 2007). Experiments
producing acute mitochondrial impairment through
ischaemia–reperfusion correspondingly demonstrate
pro-arrhythmic regional heterogeneities in ventricular
action potential duration (APD) and arrhythmogenesis
suppressed by pharmacological manipulations of the
mitochondrial membrane potential (Akar et al. 2005;
see also Brown et al. 2010). These pro-arrhythmic
changes were successfully suppressed by pharmacological
manipulations of the mitochondrial membrane potential
(Akar et al. 2005). Further work demonstrated that
stabilization of the mitochondrial membrane potential
also inhibits arrhythmias in other settings (Brown et al.
2010).
However, few experiments have explored the
effects of chronic age-dependent energetic deficiency
arising from ageing and mitochondrial dysfunction on
the generation of atrial arrhythmias or determined
their underlying electrophysiological abnormalities. The
present study used a peroxisome proliferative activated
receptor, gamma, coactivator 1 beta (Ppargc1b; hereafter
Pgc1β)-deficient (Pgc1β−/−) model (Mouse Genome
Informatics identification: MGI:2444934 (http://www.
informatics.jax.org/)) that has been used previously
to study the biochemical consequences of metabolic
energetic deficiency. This family of transcriptional
coactivators provides central regulators of cellular
and mitochondrial function controlling key metabolic
C© 2017 The Authors Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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pathways, including fatty acid oxidation, mitochondrial
biogenesis and oxidative phosphorylation. It occurs
abundantly in energetically active tissue, such as the
heart (Lin et al. 2005). Reduced Pgc1 levels and
impaired mitochondrial function occur in diabetes
mellitus, the metabolic syndrome, ageing and heart
failure (Garnier et al. 2003; Leone & Kelly, 2011).
Despite normal baseline function, Pgc1β-deficient mice
demonstrate compromised heart rate responses with
adrenergic stimulation (Lelliott et al. 2006). Their ex vivo
Langendorff-perfused hearts show ventricular arrhythmic
tendencies, abnormal diastolic Ca2+ transients and altered
ion channel expression (Gurung et al. 2011). However,
neither their atrial arrhythmic phenotypes nor their
accompanying electrophysiological changes have been
explored.
The present study complements previous reports in
murine hearts carrying genetic abnormalities in specific
ion channelsmodelling ventricular arrhythmic conditions
(Huang, 2017). The arrhythmic substrate in these different
exemplars was variously identified with altered action
potential (AP) initiation and conduction (Martin et al.
2011; Ning et al. 2016), AP recovery (Sabir et al. 2007b)
and arrhythmic triggers (Thomas et al. 2007; Goddard
et al. 2008). The present experiments, likewise, looked for
the presence of arrhythmic phenotypes provoked by the
imposition of extrasystolic S2 stimuli at differing S1S2
intervals following trains of regular S1 pacing as well as
steady-state pacing at progressively decreased basic cycle
lengths (BCLs). The findings were thenmatched to results
from simultaneous determinations of AP activation and
recovery, as well as temporal instabilities in the form
of AP alternans (Matthews et al. 2010), APD–diastolic
interval (DI) restitution relationships (Kim et al. 2002;
Matthews et al. 2012) and spatiotemporal indicators of AP
wavelength. This study represents the first to make such
measurements in murine atria. Studies in human AF have
reported increased slopes in restitution plots of APD–DI,
intervening between full AP recovery and the peak of the
subsequent AP. However, these studies did not look for
accompanying alternans (Kim et al. 2002). However, the
present findings do support previous reports associating
AF with paradoxical suppression of APD alternans in a
vagally mediated canine AF model (Lu et al. 2011).
Methods
Animals and ethical approval
This research was regulated under the Animals (Scientific
Procedures) Act 1986 Amendment Regulations 2012
following ethical review by the University of Cambridge
Animal Welfare and Ethical Review Body (Home Office
PPL no. 70/8726), and followed recommendations
provided by the Physiological Society (Grundy, 2015).
Mice were housed in an animal facility with 12 h–12 h
light–dark cycles at a temperature maintained at 21°C.
Animals were fed sterile chow (RM3 Maintenance Diet;
SDS, Witham, UK) and had free access to water, bedding
and environmental stimuli. The C57/B6 mice strain was
used as the background for both wild-type (WT) and
Pgc1β−/− mice, generated using a triple LoxP targeting
vector as previously described (Lelliott et al. 2006). Four
experimental groups were studied: young WT (n = 20),
young Pgc1β−/− (n = 23), aged WT (n = 22) and
aged Pgc1β−/− (n = 22). All young mice were aged
between 12 and 16 weeks and aged mice >52 weeks.
Mice were administered 200 IU of unfractionated heparin
(Sigma-Aldrich, Poole, UK) in the intraperitoneal space
before being killed by cervical dislocation [Schedule 1;
Animals (Scientific Procedures) Act 1986]. No recovery,
anaesthetic or surgical procedures were required.
Buffering media
Experimental solutions were based on a Krebs–Henseleit
(KH) solution of the following composition (mM): NaCl,
119; NaHCO3, 25; KCl, 4.0; KH2PO4, 1.2; MgCl2, 1.0;
CaCl2, 1.8; glucose, 10; and sodium pyruvate, 2.0; pH
adjusted to 7.4 and bubbled with 95% O2–5% CO2
(British Oxygen Company, Manchester, UK). Chemical
agents were purchased from Sigma-Aldrich (Poole, UK)
unless otherwise indicated. Before perfusion of isolated
Langendorff-perfused hearts with plain KH solution,
perfusion was initiated in the presence of 20 μM
blebbistatin (Selleckchem, Newmarket, UK) to reduce
movement and allow stable impalements.
Whole-heart intracellular microelectrode recordings
Animals were killed for rapid sternectomy and
cardiectomy. Hearts were cannulated and secured as
previously described (Zhang et al. 2011; Matthews et al.
2012; Ning et al. 2016). No obvious macroscopic defects
were observed in any heart. Hearts were then mounted on
a horizontal Langendorff apparatus that was electrically
insulated and incorporated into an intracellular rig within
aFaraday cage, incorporating a lightmicroscope (objective
×5, eyepiece ×5; W. Watson and Sons Limited, London,
UK), organ bath, custom-built microelectrode amplifier
and head stage.
To facilitate impalement of the left atrium, hearts were
mounted in a standard anatomical position to allowpacing
from the right atrium (RA) and access to the left atrium
(LA). The left atrium was displaced posteriorly and held
in place with three A1 insect pins. The positions of
the recording and stimulating electrodes were controlled
by two precision micromanipulators (Prior Scientific
Instruments, Cambridge, UK). In all experiments, the
stimulating electrode was consistently positioned at the
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posterior aspect of the RA, and recordings were made
from the central region of the LA, minimizing variability
in distances between the respective electrodes, so that
alterations in AP latencies therefore provided indications
of corresponding conduction velocity changes. Hearts
were perfused with plain KH solution (flow rate of
2.05 ml min−1) to allow establishment of a regular
intrinsic rhythm. Preparations with an intrinsic rate of
<5 Hz or which did not display 1:1 atrioventricular
conduction for >10 min postperfusion were not used for
experimentation. Perfusion with KH containing 20 μM
blebbistatin was then commenced until motion was
adequately minimized before resumption of perfusion
with plain KH solution.
A microelectrode (tip resistance 15–25 M) was
pulled by a custom-built microelectrode puller from
a glass pipette (1.2 mm o.d., 0.69 mm i.d.; Harvard
Apparatus, Cambourne, UK), filled with 3 M KCl
and then inserted into a right-angled microelectrode
holder (Harvard Apparatus). The recorded signal
from the microelectrode was passed through a head
stage for preamplification forming part of a high-
input impedance direct-current microelectrode amplifier
system (University of Cambridge, Cambridge, UK)
before bandpass filtering (between 0 and 2 kHz) and
analog-to-digital conversion at a sampling frequency of
10 kHz (1401; Cambridge Electronic Design, Cambridge,
UK). A successful impalementwas identified by the abrupt
appearance of a restingmembranepotentialmorenegative
than −70 mV and regular APs with a stable waveform. A
Ag/AgCl electrode in contact with the bath solution was
used as the reference electrode for all measurements.
Whole-heart ECG recordings
Correlation between electrical signals at the level of
the whole organ and intracellular voltage recordings
was permitted by simultaneous ECG recordings from
the Langendorff-perfused hearts. Two unipolar ECG
electrodes were placed at fixed positions adjacent to the
heart in the organ bath that corresponded to the standard
three-lead ECG co-ordinates. The recorded signals were
passed through head stages for preamplification before
amplification (Neurolog NL104 amplifier), bandpass
filtering (between 5 and 500Hz;NL 125/6 filter; Digitimer,
Welwyn Garden City, UK) and digitization at a sampling
frequency of 10 kHz (1401;CambridgeElectronicDesign).
Pacing protocols
Hearts were stimulated at an amplitude of twice diastolic
threshold voltage plus 0.5 mV. Hearts underwent two
separate pacing protocols during each experiment. First,
a standardized S1S2 protocol was used to determine the
atrial effective refractory period (AERP) from the ECG
recordings. This delivered successive trains of eight S1
stimuli separated by an interval of 125 ms, followed by a
solitary extrasystolic stimulus (S2) initially delivered 89ms
after thepreceding S1 stimulus. This patternof stimulation
was repeated with the S1S2 interval decremented by 1 ms
for each successive cycle until failure of stimulus capture.
Incremental pacing protocols then began after achieving
stable microelectrode impalement. These consisted of
cycles of regular pacing, each of 100 stimulations. They
began with a BCL of 130ms that was then decremented by
5 ms for each subsequent cycle. These were repeated until
the heart entered into 2:1 block or sustained arrhythmia.
Data and statistical analysis
Data captured by the Spike2 software package (Cambridge
Electronic Design) was analysed using a custom-written
program using the python programming language.
Alternans was defined as an occurrence of alternating
beat-to-beat changes in the value of a parameter such
that the direction of the change oscillates for at least 12
successive action potentials. Statistical analysis was carried
out using the R programming language (R Core Team,
2015) and plots with the grammar of graphics package
(Wickham, 2009). All data are expressed as means ± SD,
andaPvalueof<0.05was taken tobe significant.Different
experimental groups were compared with a two-factor
ANOVA. F values that were significant for interactive
effects prompted post hoc testing with Tukey’s honest
significant difference testing. If single comparisons were
made, Student’s two-tailed t test was used to compare
significance. Categorical variables were compared using
Fisher’s exact test. Kaplan–Meier estimates were compared
with the log rank test.
Results
Aged Pgc1β−/− hearts develop a pro-arrhythmic
phenotype
Electrocardiographic recordings were first made through
the S1S2 protocol. Extrasystolic (S2) stimuli were
interposed at successively shorter intervals following
trains of eight regular (S1) stimuli applied at a 125 ms
basic cycle length. This explored for the presence and
the frequency of arrhythmic phenotypes in the intact
ex vivo Langendorff-perfused hearts. Figure 1 shows
typical ECG recordings from aged Pgc1β−/− hearts at
a slow time base during an S1S2 stimulation protocol.
These include episodes of premature atrial complexes
following successive S2 stimuli and a short run of
atrial tachycardia captured during a typical stimulus
train at the end of an S1S2 protocol (Fig. 1A). On an
expanded time base, these could be characterized by
spontaneous atrial P waves (dashed arrow) in contrast
C© 2017 The Authors Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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to the paced P waves (continuous downward-pointing
arrows) following imposed pacing spikes (Fig. 1B,
arrowed) between successive ventricular complexes
(upward-pointing arrows). Some protocols also elicited
runs of atrial tachycardia (Fig. 1C). The S1S2 interval at
the onset of failure of stimulus capture made it possible
to determine the AERP corresponding to the specific
(8Hz) pacing rate. A comparison of AERPs obtained from
the S1S2 protocol in young WT (24.8 ± 5.8 ms), aged
WT (28.8 ± 6.1 ms), young Pgc1β−/− (29.3 ± 3.8 ms)
and aged Pgc1β−/− hearts (30.1 ± 8.9 ms) demonstrated
no significant differences between groups and provided
indications of the extent towhich BCLs could be decreased
in the succeeding incremental pacing experiments.
(V)
400 ms
50 ms
(V)
400 ms
A
B
C
Figure 1. Electrocardiographic features of pro-arrhythmic
phenotypes in Pgc-1β−/− atria
A, typical ECG recordings from S1S2 protocols, demonstrating
premature atrial complexes; dashed section is shown in B, with
an expanded time base. Continuous downward-pointing
arrows denote atrial complexes as a result of stimulation. The
dashed arrow indicates a premature atrial complex with no
preceding stimulation spike. Continuous upward-pointing
arrows denote ventricular complexes. C illustrates atrial
tachycardia in response to an S2 stimulus.
We then performed simultaneous whole-heart ECG
recordings and intracellular APmeasurements from single
cardiomyocytes after achieving stable microelectrode
impalements, with consistent stimulating and recording
electrode positions. The intracellular AP recordings
provided accurate measurements of AP characteristics
related to AP initiation, activation and recovery. These
included maximal AP upstroke rates (dV/dtmax), AP
latencies, defined as the time interval between the pacing
spike of each AP and the maximal deflection, or peak,
of the AP, AP durations at 90% recovery (APD90), and
resting membrane potentials (RMPs). The measurements
of dV/dtmax and RMPs would not have been available
with the monophasic action potential electrode methods
used on previous occasions (Sabir et al. 2007a, 2008a).
The incremental pacing protocols applied cycles of 100
regular pacing stimuli at successively decremented BCLs.
Figure 2 illustrates results of the subsequent incremental
pacing procedure comparing ECG (i) and intracellular
traces (ii) in conditions of regular activity (Fig. 2A) and
occurrences of premature atrial complexes (Fig. 2B), atrial
fibrillation (Fig. 2C) and APD90 alternans (Fig. 2D) in
an aged Pgc1β−/− heart. Individual hearts subjected to
incremental pacing could therefore display phenotypes
that differed from the results of extrasystolic (S2) stimuli.
The cycles of incremental pacing continued with
decreasing BCLs until the onset of either 2:1 capture or
arrhythmia was reached. Kaplan–Meier curves plotting
the probability of 1:1 capture of the groups as a function
of BCL (Fig. 3) demonstrated a progressive reduction in
the number of hearts continuing to show 1:1 capture
at BCLs shorter than 70 ms. This would reflect their
refractory properties at the steady-state pacing frequencies
close to this cut-off. The statistical analysis to follow will
therefore analyse data for parameters at BCLs no shorter
than 50 ms. A log rank test confirmed that the survival
curves were in fact significantly different (P = 0.0028).
YoungWT hearts showed fall-offs at shorter BCLs than in
the remaining groups and thus could be paced at higher
frequencies than the other hearts, including aged WT
hearts.
Table 1 summarizes the incidences of arrhythmic phe-
nomena, whether in the form of atrial tachycardia or
ectopic atrial deflections, through both pulse protocols.
These together suggested a more marked pro-arrhythmic
phenotype in aged Pgc1β−/− hearts than in the remaining
groups. With the S1S2 pulse protocol, the incidence
of ectopic deflections was similar between groups, but
the incidence of atrial tachycardias was greater in aged
Pgc1β−/− hearts than in young WT, aged WT or young
Pgc1β−/− hearts, which all showed similar incidences
of atrial tachycardias (P = 0.043). Hearts displaying
arrhythmias with extrasystolic (S2) provocation often
failed to show arrhythmias on incremental pacing,
and a relatively small number (three) of hearts
C© 2017 The Authors Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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(V)
30 mV
−80 mV
A(i)
A(ii)
(V)
B(i)
30 mV
−80 mV
B(ii)
(V)
10 mV
80 mV
C(i)
C(ii)
400 ms
10 mV
−90 mV
200 ms
D
Figure 2. Electrocardiographic and intracellular recordings
during incremental pacing
A, typical recordings from incremental pacing protocols
illustrating steady-state ECG recordings (i) from a wild-type
(WT) heart as well as the corresponding intracellular action
potential (AP) recordings (ii). Ectopic activity (arrow) from an
showed arrhythmia amongst the experimental groups.
The incremental pacing protocol thus resulted in few
incidences of atrial tachycardia. Nevertheless, incidences
of ectopic deflections were then greater in aged Pgc1β−/−
hearts than in young WT, aged WT and young Pgc1β−/−
hearts (P = 0.041).
Altered atrial AP characteristics in young and aged
Pgc1β−/− hearts
Figure 4 summarizes the activation and recovery chara-
cteristics of APs obtained through the incremental pacing
procedures. It illustrates the corresponding alterations in
dV/dtmax (Fig. 4A), AP latencies (Fig. 4B), APD90 (Fig. 4C),
RMP (Fig. 4D) and diastolic intervals intervening between
the attainment of 90% of AP recovery and the peak
of the subsequent action potential (DI90; Fig. 4E) with
alterations in BCL in young and aged Pgc1β−/− and
WT hearts. These parameters varied in a approximately
linear manner with BCL, and their overall magnitudes
could be compared by the areas beneath their curves.
These are summarized in Table 2 which, in addition to
showing results from the individual experimental groups
of young and agedWT and Pgc1β−/− hearts, also provides
the results of grouping all aged, young as well as WT
and Pgc1β−/− atria for the statistical analysis. Two-way
ANOVA demonstrated that the Pgc1β−/− hearts displayed
decreased dV/dtmax (P = 0.000020) and lower APD90
values (P = 0.00018) compared with WT hearts; there
were no variations in RMP between groups. Genotype
and age exerted significant interacting effects on DI90 and
AP latency values (P = 0.0081, P = 0.043, respectively).
Post hoc tests did not reveal further statistically significant
differences.
Reduced temporal heterogeneities in atrial AP
characteristics in aged Pgc1β−/− hearts
Instabilities in characteristics of successive APs, often
taking the form of episodes of alternans, presage major
ventricular arrhythmias in clinical situations. They have
been described in experimental conditions as alternating
variations in temporal properties of AP excitation and/or
recovery that occur with varying heart rates in analyses
of pro-arrhythmic tendencies associated with ventricular
arrhythmogenesis (Sabir et al. 2007a, 2008a).We sought to
analyse whether such phenomena are important in atrial
arrhythmogenesis. Figure 5 summarizes the incidences
of such alternans in the activation parameters dV/dtmax
aged Pgc1β−/− heart is shown in B, with the corresponding
ECG (i) and intracellular AP recordings (ii). C, evidence of atrial
fibrillation in the ECG (i) recording of an aged Pgc1β−/− heart,
with concurrent intracellular AP recording (ii). D illustrates AP
duration alternans in an AP recording from a young WT heart.
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Table 1. Incidences of atrial arrhythmic events during programmed electrical stimulation and incremental pacing in young and aged
wild-type (WT) and Pgc1β−/− hearts
S1S2 protocol Incremental pacing
Experimental
group
Atrial
tachycardia
Ectopic
events
Atrial
tachycardia
Ectopic
events
Young WT 3/20 8/20 0/20 2/20
Aged WT 4/23 8/23 1/23 4/23
Young Pgc1β−/− 5/23 13/23 1/23 4/23
Aged Pgc1β−/− 11/22∗ 8/22 1/22 10/22∗
Data are represented as arrhythmic over total number studied. ∗P < 0.05 on Fisher exact testing.
(Fig. 5A) and AP latency (Fig. 5B) and the recovery
parameters APD90 (Fig. 5C) and RMP (Fig. 5D) in
young and aged WT and Pgc1β−/− hearts through
the incremental pacing protocol. Overall incidences of
alternans were assessed by summing the individual
incidence of alternans at each BCL. The different groups
showed similar distributions in theoccurrenceof alternans
at different BCLs. However, statistical comparisons of
the overall incidences of alternans throughout the entire
range of BCLs indicated thatPgc1β−/− hearts have reduced
incidences and durations of alternans episodes.
Thus, two-way ANOVA demonstrated that there were
no significant effects of genotype on the incidence of
alternans in dV/dtmax, APD90, AP latency or RMP. Ageing
independently reduced the incidence of alternans in
aged compared with young hearts (dV/dtmax 24 ± 19.9
versus 39 ± 19.7 beats, P = 0.0013; APD90, 37 ±
19.9 versus 50 ± 19.7 beats, P = 0.0051; AP latency,
53 ± 19.9 versus 68 ± 19.7 beats, P = 0.00045; and
RMP, 30 ± 13.2 versus 40 ± 13.1 beats; P = 0.0011). Age
and genotype exerted interacting effects on the incidence
of AP latency alternans (P = 0.032). Post hoc testing
demonstrated less AP latency alternans in aged than
young Pgc1β−/− hearts (47 ± 23.5 versus 71 ± 14.4 beats,
P= 0.00041) and in aged Pgc1β−/− than youngWT hearts
(47 ± 23.5 versus 64 ± 22.4 beats, P = 0.036).
Likewise, two-way ANOVA demonstrated that the
magnitude of dV/dtmax, APD90 and RMP (although not
AP latency) alternans, reflected in the areas under the
respective curves, was smaller in aged than young hearts
(P = 0.037, P = 0.038, P = 0.052 and P = 0.066,
respectively; Fig. 6). There were no effects of genotype
or interacting effects of genotype and age together on the
overall magnitudes of oscillation. The total numbers of
episodes of APD90, AP latency or RMP alternans were
indistinguishable between groups, whilst Pgc1β−/− hearts
showed fewer episodes of dV/dtmax alternans than WT
hearts (8.54± 5.0 versus 13.37± 9.5 episodes of alternans,
P = 0.0021) and aged hearts fewer episodes of dV/dtmax
alternans than young hearts (9.24 ± 7.5 versus 12 ± 7.5
episodes of alternans, P = 0.030).
Maximal durations of individual episodes of dV/dtmax,
AP latency, APD90 or RMP alternans were all shorter
in aged than young hearts (dV/dtmax, 44 ± 66.3 versus
139 ± 177.0 beats, P = 0.0015; AP latency, 140 ± 126.0
versus 352 ± 183.6, P = 2.7 × 10−8; APD90, 247 ± 325.0
versus 390 ± 393.4 beats, P = 0.049; and RMP, 64 ± 66.3
versus 136 ± 131.1 beats, P = 0.0011). Although
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Figure 3. Kaplan–Meier plot of probability of 1:1 capture as basic cycle length (BCL) is varied for each
experimental group
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they were affected by interacting effects of age and
genotype (P = 0.036), post hoc testing demonstrated
that these maximal durations were shorter in both aged
Pgc1β−/− and agedWThearts than young Pgc1β−/− hearts
(98 ± 79.7 versus 379 ± 167.8 beats, P < 0.00001, and
180 ± 150.0 versus 379 ± 167.8 beats, P = 0.00029,
respectively). Furthermore, aged Pgc1β−/− hearts also
showed shortermaximal durations of AP latency alternans
than youngWThearts (98± 79.7 versus 311± 210.2 beats,
P = 0.00061).
Finally, alternans simultaneously involving different
AP characteristics could involve alternating high/low
AP latencies or reduced/increased dV/dtmax coinciding
with or, in the more pro-arrhythmic pattern, occurring
out of phase with higher/lower APD90 values. However,
reduced frequencies of simultaneous dV/dtmax and APD90
alternans occurred in aged compared with young hearts
(14.91 ± 16.1 versus 27.74 ± 19.9%, P = 0.00043)
and Pgc1β−/− compared with WT hearts (17.77 ± 2.57
versus 26.59 ± 3.23%, P = 0.024). Reduced and
similar proportions of out-of-phase alternans occurred
in Pgc1β−/− hearts compared with WT hearts (7.83 ± 9.3
versus 19.30± 30.0%; P= 0.010) and aged compared with
young hearts, respectively (P = 0.070). Likewise, reduced
frequencies of simultaneous APD90 and AP latency
alternans occurred in aged compared with young hearts
(25.67 ± 16.5 versus 45.53 ± 15.9%, P = 0.082 × 10−5),
which showed fewer beats of the more pro-arrhythmic
alternans pattern (132 ± 152.6 versus 334 ± 262.3 beats;
P = 0.00017).
Spatiotemporal representations of AP excitation
in Pgc1β−/− and WT hearts
Previous reports inmurine ventricles correlated variations
in the dependence of AP recovery upon BCL with
instabilities in the form of alternans. Restitution curves
of APD90 against BCL, or diastolic intervals (DI90) from
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90% action potential recovery (Sabir et al. 2008a,b), then
associated pro-arrhythmic instabilities with increasing
limiting slopes in APD90 versusDI90 plots with shortening
DI90 (Matthews et al. 2012). Attainment of unity gradient
presagedwaxingAPalternans and arrhythmia. In contrast,
results in Fig. 7A implicated neither genotype (two-way
ANOVA: P = 0.12) nor age (P = 0.15) in independently
influencing these limiting slopes. These factors did
interact (P = 0.0001), but this gave reduced slopes
in aged Pgc1β−/− atria (Tukey’s tests: aged Pgc1β−/−
versus aged WT, P = 0.001; aged WT versus young WT,
P = 0.001), consistent with the observed paradoxically
decreased incidences and durations of alternans in aged
and Pgc1β−/− hearts and contrasting with their increased
arrhythmogenic properties.
In contrast, analysis of spatial representations of
action potential activation, as opposed to the temporal
characteristics of AP recovery considered above, replicated
the arrhythmic phenotypes in terms of the accompanying
electrophysiological abnormalities particularly in aged
Pgc1β−/− hearts. Here, the AP travelling waves were
represented in terms of wavelengths of excited tissue
undergoing APs (λ) and resting wavelengths (λ0) of the
succeeding tissues that had completed their subsequent
AP recovery. These λ and λ0 terms were obtained by
multiplying 1/(AP latency), reflecting conduction velocity,
by the corresponding APD90 or DI90 values, respectively
(Matthews et al. 2013b). These were then compared in
young and aged WT and Pgc1β−/− atria through the
different BCLs examined. Areas under plots of λ against
BCL (Fig. 7B) then demonstrated that the Pgc1β−/− as
opposed to the WT genotype, but not age, independently
(two-way ANOVA: P = 0.6 × 10−4 and 0.14, respectively)
reduced λ. Additional, interacting effects (P = 0.048)
through the range of explored BCLs, were reflected
in the shorter λ values in both young (Tukey’s test:
P = 0.0001) and aged Pgc1β−/− (Tukey’s test: P = 0.0008)
compared with young WT atria. Likewise, λ values from
the experimental groups all declined and converged with
declining λ0 and with shortening BCL, as previously
reported (Matthews et al. 2013a; Ning et al. 2016b;
Fig. 7C). Nevertheless, λ values in aged Pgc1β−/− hearts
consistently fell below those in remaining groups (n = 14
points, sign test, P < 0.01). Accordingly, areas beneath
the curves reflected significantly greater λ at the longer
(85–130 ms; two-way ANOVA: P = 0.042) but not the
shorter (<85 ms) BCLs, resulting from interacting effects
of age andPgc1β−/− genotype (Matthews et al. 2013a;Ning
et al. 2016b).
Discussion
Both age and energetic dysfunction are known risk factors
for atrial fibrillation (Go et al. 2001; Menezes et al. 2013).
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The experimental basis for this effect was studied in
young and aged Pgc1-deficient hearts used in previous
biochemical studies of mitochondrial dysfunction. Pgc1
upregulates mitochondrial function and cellular energy
homeostasis (Lin et al. 2005; Finck & Kelly, 2006),
acting on genes involved in fatty acid oxidation and
electron transport (Arany et al. 2005). Both ageing
WT (Froehlich et al. 1978; Lakatta & Sollott, 2002;
Hatch et al. 2011; Yang et al. 2015) and energetically
deficient Pgc1β−/− hearts show abnormalities in a range
of cellularmechanismswith potential electrophysiological
consequences for arrhythmia. Their increased production
of reactive oxygen species (Grivennikova et al. 2010)
modifiesmaximal voltage-dependentNa+ andK+ current
(Wang et al. 2004; Liu et al. 2010), sarcolemmal KATP
channel function, Na+ and Ca2+ channel inactivation,
and late Na+ current and ryanodine receptor function
(Huang, 2017). The associated ATP/ADP depletion
opens sarcolemmal ATP-sensitive K+ channels (sarcKATP;
Akar & O’Rourke, 2011). Additional abnormalities in
Ca2+ homeostasis and delayed after-depolarization events
potentially initiate pro-arrhythmic triggering activity
(Gurung et al. 2011). These mechanisms could in turn
potentially alter cell–cell coupling (Smyth et al. 2010),
AP conduction (Liu et al. 2010), repolarization and
refractoriness (Wang et al. 2004), as well as predispose to
alternans and Ca2+-mediated pro-arrhythmic triggering
phenomena (Terentyev et al. 2008).
Recent studies have reported both compromised
heart rate responses to adrenergic stimulation (Lelliott
et al. 2006) and pro-arrhythmic ventricular phenotypes
in intact perfused murine Pgc1β−/− hearts (Gurung
et al. 2011). However, the corresponding atrial electro-
physiological AP or arrhythmic phenotypes have not
been investigated. In the present study, we applied
cellular electrophysiological recordings in cardiomyocytes
within intact, normally functioning Langendorff-perfused
hearts as opposed to isolated cardiomyocytes. We
thereby determined steady-state arrhythmic and related
restitution properties of murine atrial tissue for the first
time.
Our experimental approach permitted simultaneous
study of atrial arrhythmic properties of the whole heart
and electrophysiological properties of single atrial cells.
Aged Pgc1β−/− hearts demonstrated a significantly greater
incidence of arrhythmogenic phenotypes compared with
all the remaining groups. The stimulation procedures
that applied extrasystolic S2 stimuli resulted in a higher
incidence of atrial tachycardias, whereas those applying
incremental increases in steady heart rates resulted in
a higher incidence of ectopic atrial events. The latter
suggests that atrial cardiomyocytes have a greater capacity
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for rapid pacing without producing pro-arrhythmic
phenomena.
The association of the arrhythmic phenotype with
alterations in the corresponding AP characteristics was
then examined. Of the measured AP parameters, resting
membrane potentials remained uniform throughout all
experimental groups, consistent with clinical findings in
atrial fibrillation (Bosch et al. 1999). The statistically
most noticeable alterations involved compromised AP
activation, which has been implicated in arrhythmic
substrate on previous occasions (Huang et al. 2012;
King et al. 2013a; Huang, 2017). Thus, Pgc1β−/− atria
displayed decreased dV/dtmax compared with WT atria,
in the absence of statistical effects of age or interactions
between age and genotype. The dV/dtmax correlates with
peak Na+ current, which in turn markedly influences
AP conduction velocity to an extent dependent upon
the conductivity between cells (Hunter et al. 1975;
Hondeghem & Katzung, 1977; Usher-Smith et al. 2006;
Fraser et al. 2011). Although young and aged Pgc1β−/−
atria did not demonstrate significant differences in
dV/dtmax, AP latencymeasurements reflecting conduction
velocity were influenced by interactions between age and
genotype. They therefore account for the more marked
pro-arrhythmic phenotype in the aged than the young
Pgc1β−/− atria.
These findings are compatible with hypotheses
relating reduced dV/dtmax and increased AP latency to
decreased peak Na+ current in the conditions of age-
dependent mitochondrial dysfunction in Pgc1β−/− hearts
(Hondeghem & Katzung, 1977; Usher-Smith et al.
2006; Fraser et al. 2011). Established reports associate
metabolic insufficiency with reduced Na+ channel
function in a number of circumstances. First, in addition
to reduced provision of ATP, disrupted mitochondrial
activity increases production of reactive oxygen species
(Manning et al. 1984; Fosset et al. 1988; Faivre &
Findlay, 1990) andperturbs cytosolicNAD+/NADH.Both
factors are implicated in altered Na+ channel function in
metabolically stressed cardiomyocytes (Liu et al. 2009) and
are rescued by the mitochondrial reactive oxygen species
scavenger mitoTEMPO (Liu et al. 2010).
Second, Pgc1β−/− cardiomyocytes show altered Ca2+
homeostasis manifest in abnormal diastolic Ca2+
transients (Gurung et al. 2011). Other murine models
show an altered Ca2+ homeostasis implicated in slowed
AP conduction accompanying reduced dV/dtmax (Zhang
et al. 2013). These were attributed to compromised Na+
currents resulting from (i) reduced NaV1.5 expression
(Ning et al. 2016) and/or (ii) acute effects upon
NaV1.5 function (King et al. 2013b,c). These observations
were reported in RyR2-P2328S/P2328S cardiomyocytes,
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which likewise showabnormalCa2+-handling phenotypes
(Gurung et al. 2011). They also followacutemanipulations
in Ca2+ homeostasis by caffeine or Epac-mediated RyR2
agonism or cyclopiazonic acid-mediated Ca2+-ATPase
antagonism (King et al. 2013b; Li et al. 2017).
Patch-clampedWT cardiomyocytes likewise show acutely
reduced or increased Na+ current and dV/dtmax, with
respective increases in, or sequestration of, the pipette
[Ca2+] (Casini et al. 2009).
Comparisonof thepresentfindingsof reduceddV/dtmax
and increased AP latency in cardiomyocytes in intact
tissue with the normal or even enhanced Na+ currents
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in Pgc1β−/− cardiomyocytes subject to patch-clamping
involving Ca2+ chelation by intrapipette BAPTA (Gurung
et al. 2011) are compatible with a mechanism of
action involving the latter, acute effects, of altered
Ca2+ homeostasis upon membrane excitability. This
could involve Ca2+–Nav1.5 interactions involving direct
Ca2+–NaV1.5 binding at an EF hand motif close to the
NaV1.5 C-terminal (Wingo et al. 2004) or indirect Ca2+
binding involving additional ‘IQ’ domain binding sites for
Ca2+–calmodulin in the NaV1.5 C-terminal region (Mori
et al. 2000; Wagner et al. 2011; Grandi & Herren, 2014).
If so, these findings in a model for metabolic disturbance
provide a further example of potentially important effects
of intracellular Ca2+ homeostasis on arrhythmic substrate
through altering AP propagation as a result of acute effects
upon Na+ channel function.
The electrophysiological alterations of atrial cardio-
myocytes presented in this study led to investigations
to distinguish mechanisms for the resulting arrhythmic
substrate at the tissue level (Martin et al. 2012),
relating these to previous reports from monogenic
murine arrhythmic models. First, arrhythmic syndromes
primarily attributed to repolarization abnormalities have
been exemplified by murine Scn5a+/KPQ hearts.
Arrhythmic substrate was there associated with altered
relationships between APD90 and effective refractory
period with varying diastolic interval (DI90; Nolasco &
Dahlen, 1968; Sabir et al. 2008a; Matthews et al. 2010,
2012) increasing the steepness of restitution curve plots of
APD90 against DI90 at short BCLs. The consequent APD90
instabilities would increase frequencies and amplitudes of
alternans, culminating in arrhythmic substrate (Huang,
2017).
However, the present findings did not implicate such
alternans in the arrhythmic instability in aged Pgc1β−/−
atria. Atrial alternans was observed in AP trains during
incremental steady-state pacing. However, its incidence
was not increased by age or Pgc1β−/− genotype. Indeed,
aged atria showed decreased incidences of alternans
compared with young hearts. The Pgc1β−/− and aged atria
showed fewer episodes of alternans than WT and young
atria, respectively. Furthermore, it was the restitution
curves of aged Pgc1β−/− hearts that showed the most
reduced limiting slopes. These findings parallel previous
reports in the vagally induced model of canine AF that
likewise showed paradoxically less alternans and a flatter
restitution slope than in the non-arrhythmic control state
(Lu et al. 2011). Atrial Pgc1β−/− cardiomyocytes thus
showed greater capacity to follow rapid pacing without
producing pro-arrhythmic alternans phenomena. This
would be compatible with their shorter APDs reflecting
more rapid AP recoveries, despite their more prolonged
activation processes.
Second, other arrhythmic syndromes have been contra-
stingly attributed to alteredAP conduction, exemplified by
C© 2017 The Authors Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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murine Scn5a+/− hearts (Martin et al. 2012). Thismodifies
the spatial extent and homogeneity of the travelling waves
of AP excitation, or the quiescence that follows it. These
were quantified by active wavelengths (λ) derived from
conduction velocity [reflected by 1/(AP latency)] and
APD terms (given by APD90; Matthews et al. 2013), and
resting wavelengths (λ0) comprising DI90 and AP latency
terms (Matthews et al. 2013; Ning et al. 2016). Larger
λ values reduce likelihoods that areas of depolarization
and repolarization coincide at tissue heterogeneities,
increasing the safety factor that ensures continued
undisrupted propagation of the travelling wave (Weiss
et al. 2005). Conversely, decreased λ values increase such
likelihoods and those of the consequent wave break-ups
intomultiplewavelets, scroll-waves (Davidenko et al. 1995;
Zaitsev et al. 2000; Pandit & Jalife, 2013) and further
wavebreaks disrupting the AP conduction pathways
(Spector, 2013). Clinical observations correspondingly
associate short AP wavelengths with AF inducibility and
maintenance (Hwang et al. 2015), particularly in AF
patients (Padeletti et al. 1995).
The present analysis indeed demonstrated that in plots
of λ against either BCL or λ0, Pgc1β−/− and, particularly,
aged Pgc1β−/− atria consistently gave shorter λ in direct
parallel with their pro-arrhythmic phenotype. Altered AP
conduction with its consequences for its spatiotemporal
properties thus constitutes a potential mechanism for
the atrial arrhythmic changes associated with age and
energetic compromise reported here.
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